Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again.

clinical research/practice donors and donation donors and donation: deceased donors and donation: donation after brain death (DBD) donors and donation: donation after circulatory death (DCD) donors and donation: extended criteria health services and outcomes research liver transplantation/hepatology organ procurement and allocation organ transplantation in general

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
01 2020
Historique:
received: 17 04 2019
revised: 20 06 2019
accepted: 09 07 2019
pubmed: 23 7 2019
medline: 12 1 2021
entrez: 23 7 2019
Statut: ppublish

Résumé

Our main objective was to compare liver transplant (LT) results between donation after circulatory death (DCD) and donation after brainstem death (DBD) in our hospital and to analyze, within the DCD group, the influence of age on the results obtained with DCD donors aged >70 years and up to 80 years. All DCD-LTs performed were analyzed prospectively. The results of the DCD group were compared with those of a control group who received a DBD-LT immediately after each DCD-LT. Later, the results obtained within the DCD group were analyzed according to the age of the donors, considering 2 subgroups with a cut-off point at 70 years. Survival results for LT with DCD and super rapid recovery were not inferior to those obtained in a similar group of patients transplanted with DBD livers. However, the cost of DCD was a higher rate of biliary complications, including ischemic cholangiopathy. Donor age was not a negative factor.

Identifiants

pubmed: 31329359
doi: 10.1111/ajt.15537
pii: S1600-6135(22)10055-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-212

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Abbass AA, Abouljoud M, Yoshida A, et al. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease. TPS. 2010;42:3392-3398. https://doi.org/10.1016/j.transproceed.2010.07.099.
Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transplant. 2008;14(12):1694-1707. https://doi.org/10.1002/lt.21668.
Meurisse N, Vanden Bussche S, Jochmans I, et al. Outcomes of liver transplantations using donations after circulatory death: a single-center experience. Transplant Proc. 2012;44:2868-2873. https://doi.org/10.1016/j.transproceed.2012.09.077.
Reich DJ, Hong JC. Current status of donation after cardiac death liver transplantation. Curr Opin Organ Transplant. 2010;15(3):316-321. https://doi.org/10.1097/mot.0b013e32833991e3.
Broomhead RH, Patel S, Fernando B, O'Beirne J, Mallett S. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transplant. 2012;18(7):771-778. https://doi.org/10.1002/lt.23406.
O'Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159-1174. https://doi.org/10.1111/tri.12403.
de Haan JE, Kalisvaart M, Wijnhoven BPL, et al. Comparison of postoperative outcomes between donation after circulatory death and donation after brain death liver transplantation using the comprehensive complication index. Ann Surg. 2017;266(5):772-778. https://doi.org/10.1097/sla.0000000000002419.
Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97(5):744-753. https://doi.org/10.1002/bjs.7043.
Hessheimer AJ, Coll E, Domínguez-Gil B, Turrión S, Fondevila C. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2019;70:658-665. https://doi.org/10.1016/j.jhep.2018.12.013.
Doyle MB, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015;221:142-152. https://doi.org/10.1016/j.jamcollsurg.2015.03.053.
Organización Nacional de Trasplantes. Protocolo Nacional de Donación y Trasplante Hepático En Donación En Asistolia Controlada. 2015. http://www.ont.es/infesp/DocumentosDeConsenso/PROTOCOLO NACIONAL DE DONACIÓN Y TRASPLANTE HEPÁTICO EN DONACIÓN EN ASISTOLIA CONTROLADA_Agosto 2015_FINAL.pdf. Accessed March 20, 2019.
Martín-Delgado MC, Martínez-Soba F, Masnou N, et al. Summary of Spanish recommendations on intensive care to facilitate organ donation. Am J Transplant. 2019;19:1782-1791. https://doi.org/10.1111/ajt.15253.
Chapman WC, Vachharajani N, Collins KM, et al. Donor age-based analysis of liver transplantation outcomes: short-and long-term outcomes are similar regardless of donor age. J Am Coll Surg. 2015;221:59-69. https://doi.org/10.1016/j.jamcollsurg.2015.01.061.
Barbier L, Cesaretti M, Dondero F, et al. Liver transplantation with older donors. Transplantation. 2016;100(11):2410-2415. https://doi.org/10.1097/tp.0000000000001401.
Darius T, Monbaliu D, Jochmans I, et al. Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation. TPS. 2012;44:2861-2867. https://doi.org/10.1016/j.transproceed.2012.09.076.
Harring TR, Thao N, Nguyen T, et al. Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res. 2012;178:502-511. https://doi.org/10.1016/j.jss.2012.04.044.
Detry O, Deroover A, Meurisse N, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg. 2014;101(7):784-792. https://doi.org/10.1002/bjs.9488.
Cascales-Campos PA, Ramírez P, González-Sánchez MR, et al. Orthotopic liver transplantation with elderly donors (over 80 years of age): a prospective evaluation. Transplant Proc. 2018;50(10):3594-3600. https://doi.org/10.1016/j.transproceed.2018.08.005.
Martinez-Insfran LA, Ramirez P, Cascales P, et al. Early outcomes of liver transplantation using donors after circulatory death in patients with hepatocellular carcinoma: a comparative study. Transplant Proc. 2019;51:359-364. https://doi.org/10.1016/j.transproceed.2018.10.021.
Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation. 1995;59:197-203. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035834/pdf/nihms257283.pdf. Accessed March 20, 2019.
Witjes M, Kotsopoulos AMM, Otterspoor L, et al. The implementation of a multidisciplinary approach for potential organ donors in the emergency department. Transplantation. 2019. https://doi.org/10.1097/tp.0000000000002701
Hansen T, Hollemann D, Pitton MB, et al. Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation-a morphological clue to ischemic-type biliary lesion? Virchows Arch. 2012;461:41-48. https://doi.org/10.1007/s00428-012-1245-8.
Brunner SM, Junger H, Ruemmele P, et al. Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol. 2013;58:1133-1139. https://doi.org/10.1016/j.jhep.2012.11.046.
Hessheimer AJ, Cárdenas A, García-Valdecasas JC, Fondevila C. Can we prevent ischemic-type biliary lesions in donation after circulatory determination of death liver transplantation? Liver Transplant. 2016;22(7):1025-1033. https://doi.org/10.1002/lt.24460.
Sherlock S, Dooley J. Sclerosing cholangitis. In: Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary System. 11th ed. London: Blackwell Publishing; 2002:255-265.
Mourad MM, Algarni A, Liossis C, Bramhall SR, Lios-Sis C. Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol. 2014;20:6159-6169. https://doi.org/10.3748/wjg.v20.i20.6159.
Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long term outcomes from a single center. Ann Surg. 2011;253:817-825. https://doi.org/10.1097/sla.0b013e3182104784.
Watson CJE, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19:1745-1758. https://doi.org/10.1111/ajt.15241.
Gilbo N, Jochmans I, Sainz-Barriga M, et al. Age matching of elderly liver grafts with elderly recipients does not have a synergistic effect on long-term outcomes when both are carefully selected. Transplant Direct. 2019;5(4):e342. https://doi.org/10.1097/txd.0000000000000883.
Croome KP, Mathur AK, Lee DD, et al. Outcomes of donation after circulatory death liver grafts from donors 50 years or older: a multicenter analysis. Transplantation. 2018;102(7):1108-1114. https://doi.org/10.1097/tp.0000000000002120.
Schlegel A, Scalera I, Perera MTPR, et al. Impact of donor age in donation after circulatory death liver transplantation: is the cutoff “60” still of relevance? Liver Transplant. 2018;24(3):352-362. https://doi.org/10.1002/lt.24865.
Haugen CE, Bowring MG, Holscher CM, et al. Survival benefit of accepting livers from deceased donors over 70 years old. Am J Transplant. 2019;19:2020-2028. https://doi.org/10.1111/ajt.15250.
Le Dinh H, de Roover A, Kaba A, et al. Donation after cardio-circulatory death liver transplantation. World J Gastroenterol. 2012;18(33):4491-4506. https://doi.org/10.3748/wjg.v18.i33.4491.
Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011;253(2):259-264. https://doi.org/10.1097/sla.0b013e318204e658.

Auteurs

Pedro A Cascales-Campos (PA)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

David Ferreras (D)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Felipe Alconchel (F)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Beatriz Febrero (B)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Mario Royo-Villanova (M)

Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Intensive Care Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

María Martínez (M)

Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Intensive Care Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

José M Rodríguez (JM)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Juan Á Fernández-Hernández (JÁ)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Antonio Ríos (A)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

José A Pons (JA)

Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Department of Hepatology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

Francisco Sánchez-Bueno (F)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Ricardo Robles (R)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Enrique Martínez-Barba (E)

Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Department of Patholoy, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

Laura Martínez-Alarcón (L)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Pascual Parrilla (P)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Pablo Ramírez (P)

Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH